DadFinStart your free week
DadFin › Stocks › Healthcare › ICLR

ICON Public Limited Company (ICLR) stock score

Healthcare · Diagnostics & Research · Ireland

$164.17 ▼ -0.20% today

45.4
Dad Score, out of 100
middling

ICON Public Limited Company (ICLR) is a Diagnostics & Research company in the Healthcare sector, listed in Ireland. On DadFin's weekly run it scores 45.4 out of 100 on the Dad Score, a middling reading that places the business ahead of 45% of the 5,774 US and Canadian stocks DadFin fully scores. Inside Healthcare it ranks #463 of 974. Its strongest axes are valuation, quality and liquidity; its weakest are growth and risk.

Scores from the run of Oct 4, 2026. The Dad Score answers one question: how good is this business, measured against its own sector. How it is built →

The eight axes

Valuation
Above average
Quality
Above average
Growth
Below average
Price action
Average
Risk
Below average
Conviction
Below average
Liquidity
Strong
Macro
Average

Each axis is ranked inside the stock's own sector. Subscribers see the percentile and every input behind each bar.

Key numbers

P/E (trailing)249.3×
P/E (forward)13.7×
Dividend yield0.00%
Return on capital3.4%
Operating margin9.4%
Revenue growth (YoY)+0.8%
FCF yield5.7%
Net debt / EBITDA4.96×
Piotroski F-Score6 / 9
52-week change-14.9%
Market cap$12.5B
Next earningsOct 21, 2026

What subscribers see on ICLR

Start your free weekSubscriber? Open the full research →

Diagnostics & Research peers

StockCompanyDad ScoreBandMarket cap
TMOThermo Fisher Scientific Inc.77.0good$242.1B
DHRDanaher Corporation79.6good$150.5B
NTRANatera, Inc.86.1strong$59.1B
AAgilent Technologies, Inc.79.9good$47.3B
IQVIQVIA Holdings Inc.82.3good$42.5B
WATWaters Corporation78.8good$41.7B
ILMNIllumina, Inc.35.1weak$41.2B
IDXXIDEXX Laboratories, Inc.90.1strong$40.9B

Prices from DadFin's live feed (refreshed about every 15 minutes in the session); scores from the weekly run of Oct 4, 2026. Fundamentals as reported in the latest filings. Research, not investment advice.